Kidney Health: Can Mom's Health During Pregnancy Make a Difference?
"New research explores how a mother's health during and after pregnancy affects her child's kidney health, offering hope for managing conditions like Polycystic Kidney Disease (PKD)."
The health of a mother during pregnancy and immediately after childbirth has long-lasting effects on her child. Groundbreaking studies have shown that a mother's well-being during these crucial times can influence everything from the baby's weight at birth to their risk of developing diseases later in life, including high blood pressure, kidney problems, and diabetes.
When it comes to kidney health, these early stages of development are especially important. The kidneys are particularly susceptible to disturbances in the womb, with any issues potentially leading to reduced nephron endowment—the number of filtering units in the kidney. This reduction can lead to future health complications.
A recent study sheds light on how the prenatal and postnatal maternal environments impact kidney health, particularly concerning nephron endowment, renal function, and blood pressure in the context of Polycystic Kidney Disease (PKD). PKD is a genetic disorder causing cysts to grow in the kidneys, which can lead to serious health issues. This research offers hope and potential strategies for mitigating the disease's impact through careful maternal care.
The Current Burden
CDC data report 6.0 million U.S. adults age 18 and older with diagnosed kidney disease, representing 2.4% of adults, based on the 2018 National Health Interview Survey. The CDC also reports 54,358 deaths from nephritis, nephrotic syndrome, and nephrosis, or 16.4 deaths per 100,000 population. The 2025 review on global inequities emphasizes that kidney disease during pregnancy is also shaped by health disparities and calls for interventions and policies to improve pregnancy outcomes. The USRDS 2025 Annual Data Report tracks chronic kidney disease in the general population, identification and care, morbidity and mortality, acute kidney injury, and kidney disease among children and adolescents.
A Careful Clinical Approach
Evaluation of kidney health during and after pregnancy generally requires individualized clinical assessment rather than a single universal test or prediction. Clinicians may consider medical history, kidney-function measurements, blood pressure, urine findings, and pregnancy-related changes together. Results can be difficult to interpret because pregnancy itself changes normal physiology, and early kidney disease may not cause obvious symptoms. Ongoing research may improve risk assessment, but current conclusions should be applied cautiously and with appropriate clinical follow-up.
From Observation to Opportunity
Recent work has used kidney ultrasound and function data from mothers and newborn infants, including minimally invasive ultrasound methods, to investigate how maternal health may affect infant kidney development. A 2025 editorial describes pregnancy as an overlooked open window for early chronic kidney disease detection, management, and lifelong health planning. Comprehensive reviews now address both primary kidney diseases and pregnancy-induced conditions, including their natural history, management, and effects on pregnancy. The National Kidney Foundation also describes 75 years of kidney-care progress through research, innovation, patient advocacy, and community support.
Understanding the Study: Maternal Health's Impact on Kidney Development
The study, published in the Journal of Developmental Origins of Health and Disease, investigated the effects of maternal health on kidney development using a rodent model of PKD—the Lewis polycystic kidney (LPK) rat. Researchers compared LPK pups born and raised under different maternal conditions to understand how prenatal and postnatal environments influence kidney health.
- Control Group (LPK): Pups born from and raised by mothers with the full PKD phenotype, representing a less-than-ideal prenatal and postnatal environment.
- Postnatal Improvement Group (LPK:Pn): Pups born from LPK mothers but cross-fostered to healthy heterozygous LPK mothers immediately after birth, improving their postnatal environment.
- Prenatal and Postnatal Improvement Group (LPK:Pr/Pn): Pups born from and raised by healthy heterozygous LPK mothers, thus experiencing improved prenatal and postnatal conditions.
- Genetic Background Variation Group (WKY-LPK:Pr/Pn): Pups born from and raised by healthy heterozygous mothers on a different genetic background (Wistar Kyoto), to explore whether genetic factors play a role in outcomes.
What Current Reviews Show
A 2024 Nature Reviews review examines reproductive-health issues across the reproductive life course for people with kidney disease. It reports that chronic kidney disease can negatively affect both male and female fertility through factors including inflammation, hormonal dysregulation, reduced ovarian reserve, and reduced sperm quality. A comprehensive review of kidney disease and pregnancy covers common primary and pregnancy-induced kidney diseases, their natural history, management, and effects on pregnancy. Together, these reviews frame kidney health as relevant before conception, during pregnancy, and beyond delivery.
Limits of the Evidence
Evidence about how maternal kidney health affects a child's later kidney health remains complex and should not be reduced to a single cause-and-effect explanation. Pregnancy-related physiology, pre-existing disease, treatment, genetics, and social conditions may all influence observed outcomes. Studies may also differ in populations, measurements, and follow-up periods, making direct comparisons difficult. These limitations support cautious interpretation and individualized medical advice rather than broad conclusions for every pregnancy.
Comparing Risks and Contexts
Comparisons of pregnancy and kidney outcomes should account for differences in the type and severity of kidney disease, whether disease was present before pregnancy, and the care available to the patient. A result observed in one population may not apply equally to people with different stages of disease or different health systems. The available material supports examining these contexts separately rather than treating all kidney disease in pregnancy as one uniform condition. Careful comparison can therefore clarify patterns without implying that every patient faces the same risk.
Key Findings and What They Mean for Kidney Health
The study revealed several significant findings:<ul><li><b>Nephron Endowment:</b> LPK rats had approximately 25% fewer nephrons than their healthy counterparts, highlighting the impact of the disease on kidney development.</li><li><b>Improved Growth and Function:</b> Pups in the improved environment groups (LPK:Pr/Pn and WKY-LPK:Pr/Pn) showed better postnatal growth, improved kidney function, and reduced blood pressure compared to the control group.</li><li><b>Genetic Influence:</b> The WKY-LPK:Pr/Pn group, with a different genetic background, exhibited the most significant improvements, suggesting that genetic factors can interact with maternal environment to influence outcomes.</li><li><b>Postnatal Impact:</b> Even improving the postnatal environment alone (LPK:Pn) led to some benefits, though less pronounced than when both prenatal and postnatal conditions were optimized.</li></ul>These findings underscore the importance of both prenatal and postnatal maternal health in shaping kidney development and function. A healthy maternal environment can mitigate the severity of PKD and potentially delay disease progression.
Pregnancy as a Health Signal
The available evidence presents pregnancy as both a period requiring attention to kidney health and a possible opportunity to identify kidney problems earlier. Reviews emphasize that kidney disease can affect reproductive health, pregnancy management, and outcomes for the mother and child. At the same time, the relationship is medically complex and requires assessment of the individual rather than reliance on a general rule. Early discussion with healthcare professionals can help connect pregnancy care with longer-term kidney-health planning.
Earlier Detection and Follow-Up
One review estimates that early-stage chronic kidney disease is present in 3 of every 100 pregnancies, while later-stage disease affects 1 in 750 pregnancies. It also notes that pregnancy rates are increasing among women with chronic kidney disease risk factors such as obesity and advanced maternal age, potentially increasing the number of pregnancies affected by CKD. The International Society of Nephrology describes pregnancy as an important window for detecting and diagnosing kidney conditions and for understanding future kidney and cardiovascular health. The National Kidney Foundation recommends discussing pregnancy in advance with a doctor or other healthcare provider when kidney disease or kidney failure is present.
Care Beyond Pregnancy
Pregnancy care can provide an opportunity to investigate, manage, and follow early signs of kidney disease both during pregnancy and later in a woman's life. This approach requires continuity rather than treating kidney findings as relevant only until delivery. Broader challenges include recognizing kidney disease early and ensuring that follow-up remains connected to ongoing health care. Guidance on kidney issues during pregnancy also highlights physiological changes, chronic kidney disease, and preeclampsia as important parts of management.
Personalized Support Matters
Kidney disease can make decisions about pregnancy more complicated for individuals and families, particularly when concerns involve both the pregnant person and the unborn child. People may need clear explanations of risks, treatment choices, monitoring, and follow-up. Because kidney conditions and pregnancy circumstances vary, supportive care should be individualized rather than based on assumptions. Shared decision-making with appropriate healthcare professionals can help patients plan care around their own health goals and needs.